IL6 and thyroid cancer: In another study, IL‐6 levels were higher in thyroid cancer cell lines with inherent apoptosis resistance to RAF‐MAPK inhibitors than RAF‐MAPK inhibitor‐sensitive melanoma and colon cancer cell lines (Sos et al., 2014).